Associate Attending Physician
Memorial Sloan Kettering Cancer Center
New York, New York
Jae Park, MD is Associate Attending Physician in the Division of Hematologic Oncology, Leukemia Service, and a Director of Adult Acute Lymphoblastic Leukemia Program and Chief of Cellular Therapy Service at Memorial Sloan Kettering Cancer Center in New York City, New York. Dr. Park received his medical degree from the Johns Hopkins School of Medicine and completed an internal medicine residency at Massachusetts General Hospital and a hematology/oncology fellowship at Memorial Sloan Kettering Cancer Center. Dr. Park has written or co-written numerous peer-reviewed articles appearing in New England Journal of Medicine, Lancet, Nature Medicine, Science Translational Medicine, Blood, Cancer Discovery, Leukemia and Journal of Clinical Oncology. His research has been recognized and funded by the ASH, AACR, ASCO, Leukemia and Lymphoma Society, Geoffrey Beene Research Foundation, and NCCN. His research focus is to translate and establish novel targeted and immunotherapies for patients with hematologic malignancies. He is the principal investigator of several clinical trials in adult patients with ALL and CLL/NHL using CAR T and IEC therapies, BiTEs, IDCs, targeted agents, and immunomodulators.